If a researcher introduces a novel compound that completely inhibits phospholipase A2 (PLA2) activity in macrophages stimulated with lipopolysaccharide (LPS), which consequence follows regarding the inflammatory response?

💡 Explanation

Inhibiting PLA2 prevents the release of arachidonic acid, the precursor to prostaglandins, because PLA2 catalyzes its release from membrane phospholipids. Therefore, prostaglandin synthesis decreases, attenuating inflammation, rather than increasing leukotriene production or thromboxane synthesis, which depend on different pathways.

• Why does chronic nerve compression lead to amplified pain signals from nociceptors even after the compression is relieved?
• What causes increased susceptibility to autoimmune diseases when regulatory T cells (Tregs) are functionally impaired during early childhood development?
• If a prosthetic hand's touch sensors are designed to mimic rapidly adapting (RA) mechanoreceptors, which consequence follows during object manipulation?
• Which failure mode becomes likely when chronic psychological stress impairs proteasome function within muscle cells undergoing age-related sarcopenia?
• A burn patient with extensive skin damage experiences increased susceptibility to bacterial infections. Which mechanism explains why this occurs in the compromised integumentary system?
• Why does impaired oxygen delivery to tissues occur in iron deficiency anemia despite adequate lung function?